Profile
Stephen T.
Isaacs is the founder of Cerus Corp.
which was founded in 1991.
He was the President & Chief Executive Officer of Cerus Corp.
from 1991 to 2004.
Currently, he is the Chairman of X-Biotix Therapeutics, Inc. since 2018 and also the Director of the Center for Global Development.
He was also a Principal at the University of California, Berkeley from 1986 to 1986.
Mr. Isaacs received his undergraduate degree from the University of California, Berkeley in 1973.
Stephen T. Isaacs active positions
| Companies | Position | Start |
|---|---|---|
X-Biotix Therapeutics, Inc.
X-Biotix Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development in biotechnology | Chairman | 31/03/2018 |
Center for Global Development
Center for Global Development Miscellaneous Commercial ServicesCommercial Services Works to reduce global poverty and inequality through research | Director/Board Member | - |
Former positions of Stephen T. Isaacs
| Companies | Position | End |
|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Chief Executive Officer | 04/10/2020 |
Oncologic, Inc.
Oncologic, Inc. BiotechnologyHealth Technology Develops patented technology for cancer treatment | President | 01/06/2008 |
| CERUS CORPORATION | Chief Executive Officer | 31/12/2003 |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 31/12/1985 |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Chief Executive Officer | - |
Training of Stephen T. Isaacs
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Cerus Corp.
Cerus Corp. Medical SpecialtiesHealth Technology Develops and commercializes the INTERCEPT Blood System for platelets and plasma | Health Technology |
Oncologic, Inc.
Oncologic, Inc. BiotechnologyHealth Technology Develops patented technology for cancer treatment | Health Technology |
Aduro BioTech, Inc.
Aduro BioTech, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company, which focuses on the development of technology platforms for cancer | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Center for Global Development
Center for Global Development Miscellaneous Commercial ServicesCommercial Services Works to reduce global poverty and inequality through research | Commercial Services |
X-Biotix Therapeutics, Inc.
X-Biotix Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
- Stock Market
- Insiders
- Stephen T. Isaacs
















